Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings. Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated Infections Prevention Program WSLH AST Conference May 10, 2012. Key premise.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Gwen Borlaug, CIC, MPH
Coordinator, Healthcare-Associated Infections Prevention Program
WSLH AST Conference
May 10, 2012
The laboratory is a critical partner in preventing transmission of carbapenem-resistant Enterobacteriaceae (CRE) in healthcare settings.
E. coli, Klebsiella spp., and Enterobacter spp. made up 21% of all healthcare-associated infections (HAI) in 2006-07.
Hidron et al. Infect Control Hosp Epidemiol 2008;29:996-1011
Because these organisms pose a threat to patients in acute care settings, are difficult to treat and cause increased mortality, cost, and length of stay, CDC is urging state health departments to determine prevalence and contain these organisms before they become endemic.
In Wisconsin, the approach is to determine prevalence in acute care facilities using the National Healthcare Safety Network, to detect patients with CRE infections/colonization quickly through recommended laboratory methods, and to promptly apply strict infection control methods.
Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute
care facilities. MMWR 58 (10); 256-260